173 related articles for article (PubMed ID: 33048355)
21. Germline mutational analysis of CDH1 and pathologic features in familial cancer syndrome with diffuse gastric cancer/breast cancer proband in a Chinese family.
Zhu ZG; Yu YY; Zhang Y; Ji J; Zhang J; Liu BY; Chen XH; Lu Y; Jiang HS; Bu L; Hu LD; Kong XY
Eur J Surg Oncol; 2004 Jun; 30(5):531-5. PubMed ID: 15135482
[TBL] [Abstract][Full Text] [Related]
22. CDH1 germline mutations in a Chinese cohort with hereditary diffuse gastric cancer.
Pan Z; Fu Z; Luo C; Bao Y; Wang M; Cao W; Xu X
J Cancer Res Clin Oncol; 2022 Aug; 148(8):2145-2151. PubMed ID: 34537906
[TBL] [Abstract][Full Text] [Related]
23. Screening E-cadherin germline mutations in Italian patients with familial diffuse gastric cancer: an analysis in the District of Urbino, Region Marche, Central Italy.
Graziano F; Ruzzo AM; Bearzi I; Testa E; Lai V; Magnani M
Tumori; 2003; 89(3):255-8. PubMed ID: 12908778
[TBL] [Abstract][Full Text] [Related]
24. Genetic predisposition to gastric cancer.
Petrovchich I; Ford JM
Semin Oncol; 2016 Oct; 43(5):554-559. PubMed ID: 27899187
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer.
Ku GY; Kemel Y; Maron SB; Chou JF; Ravichandran V; Shameer Z; Maio A; Won ES; Kelsen DP; Ilson DH; Capanu M; Strong VE; Molena D; Sihag S; Jones DR; Coit DG; Tuvy Y; Cowie K; Solit DB; Schultz N; Hechtman JF; Offit K; Joseph V; Mandelker D; Janjigian YY; Stadler ZK
JAMA Netw Open; 2021 Jul; 4(7):e2114753. PubMed ID: 34251444
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.
Pearlman R; Frankel WL; Swanson B; Zhao W; Yilmaz A; Miller K; Bacher J; Bigley C; Nelsen L; Goodfellow PJ; Goldberg RM; Paskett E; Shields PG; Freudenheim JL; Stanich PP; Lattimer I; Arnold M; Liyanarachchi S; Kalady M; Heald B; Greenwood C; Paquette I; Prues M; Draper DJ; Lindeman C; Kuebler JP; Reynolds K; Brell JM; Shaper AA; Mahesh S; Buie N; Weeman K; Shine K; Haut M; Edwards J; Bastola S; Wickham K; Khanduja KS; Zacks R; Pritchard CC; Shirts BH; Jacobson A; Allen B; de la Chapelle A; Hampel H;
JAMA Oncol; 2017 Apr; 3(4):464-471. PubMed ID: 27978560
[TBL] [Abstract][Full Text] [Related]
27. Mutational separation and clinical outcomes of
Liu HL; Peng H; Huang CH; Zhou HY; Ge J
World J Gastrointest Surg; 2023 Dec; 15(12):2855-2865. PubMed ID: 38222005
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
[TBL] [Abstract][Full Text] [Related]
29. Genomic profile analysis of diffuse-type gastric cancers.
Lee YS; Cho YS; Lee GK; Lee S; Kim YW; Jho S; Kim HM; Hong SH; Hwang JA; Kim SY; Hong D; Choi IJ; Kim BC; Kim BC; Kim CH; Choi H; Kim Y; Kim KW; Kong G; Kim HL; Bhak J; Lee SH; Lee JS
Genome Biol; 2014 Apr; 15(4):R55. PubMed ID: 24690483
[TBL] [Abstract][Full Text] [Related]
30. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
[TBL] [Abstract][Full Text] [Related]
31. CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer.
Adib E; El Zarif T; Nassar AH; Akl EW; Abou Alaiwi S; Mouhieddine TH; Esplin ED; Hatchell K; Nielsen SM; Rana HQ; Choueiri TK; Kwiatkowski DJ; Sonpavde G
Br J Cancer; 2022 Mar; 126(5):797-803. PubMed ID: 34949788
[TBL] [Abstract][Full Text] [Related]
32. CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment.
Luo W; Fedda F; Lynch P; Tan D
Front Pharmacol; 2018; 9():1421. PubMed ID: 30568591
[TBL] [Abstract][Full Text] [Related]
33. New germline mutations in BRCA1, ATM, MUTYH, and RAD51D genes in Tuvans early-onset breast cancer patients.
Gervas P; Molokov A; Ivanova A; Panferova Y; Kiselev A; Chernyshova A; Pisareva L; Choynzonov E; Cherdyntseva N
Exp Oncol; 2021 Mar; 43(1):52-55. PubMed ID: 33785725
[TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.
Garziera M; Canzonieri V; Cannizzaro R; Geremia S; Caggiari L; De Zorzi M; Maiero S; Orzes E; Perin T; Zanussi S; De Paoli P; De Re V
PLoS One; 2013; 8(10):e77035. PubMed ID: 24204729
[TBL] [Abstract][Full Text] [Related]
35. Frequency and Clinical Characteristics of Unselected Korean Gastric Cancer Patients with a Germline
Shin S; Kim Y; Lee JK; Lee KA
J Cancer; 2020; 11(1):208-212. PubMed ID: 31892987
[No Abstract] [Full Text] [Related]
36. Germline likely pathogenic variants in ataxia-telangiectasia-mutated gene in an Iranian family with hereditary diffuse gastric cancer without
Kheirollahi M; Saneipour M; Moridnia A
J Cancer Res Ther; 2021; 17(6):1434-1437. PubMed ID: 34916374
[TBL] [Abstract][Full Text] [Related]
37. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice.
Graziano F; Humar B; Guilford P
Ann Oncol; 2003 Dec; 14(12):1705-13. PubMed ID: 14630673
[TBL] [Abstract][Full Text] [Related]
38. Clinical features and cancer risk in families with pathogenic
Xicola RM; Li S; Rodriguez N; Reinecke P; Karam R; Speare V; Black MH; LaDuca H; Llor X
J Med Genet; 2019 Dec; 56(12):838-843. PubMed ID: 31296550
[TBL] [Abstract][Full Text] [Related]
39. Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing.
Cai H; Jing C; Chang X; Ding D; Han T; Yang J; Lu Z; Hu X; Liu Z; Wang J; Shang L; Wu S; Meng P; Lin L; Zhao J; Nie M; Yin K
J Transl Med; 2019 Jun; 17(1):189. PubMed ID: 31164161
[TBL] [Abstract][Full Text] [Related]
40. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]